NLRP3 and glioma: Pyroptosis offers novel therapeutic strategies, such as targeting GSDMD, NLRP3, or ncRNAs like miR-214 and circWEE1, to enhance TMZ sensitivity, overcome resistance, and curb glioma progression (Fig. 3A).